Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

ENZN 1.02 -0.01 (-0.97%)
price chart
Enzon Pharmaceuticals Inc (ENZN): Warning! Enzon Pharmaceuticals Is ...
Finance profile for the company! Right off the bat, that doesn't give us a lot of confidence, now does it? Enzon Pharmaceuticals (NASDAQ:ENZN) used to be a research stage biotech firm, focusing on a technology known as PEGylation. PEGylation was used ...
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)
Compared to other companies in the Biotechnology industry and the overall market, ENZON PHARMACEUTICALS INC's return on equity significantly exceeds that of both the industry average and the S&P 500.
Legendary Investor Icahn Still Slugging Away With Enzon Pharma
Carl C. Icahn has been the principal beneficial shareholder of Icahn Enterprises L.P. (NASDAQ:IEP) and has served as Chairman of the board, a director, and an owner of the company's general partner since 1990. Mr. Icahn heads the investment ...
Related articles »  
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
Orphan drugs, as they're known in the pharmaceutical industry, treat diseases that afflict fewer than 200,000 patients in the United States.
Related articles »  
Enzon Pharmaceuticals, Inc. (ENZN): Are Hedge Funds Right About This Stock?
Is Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) a buy, sell, or hold? The best stock pickers are taking a bearish view.
Receptos Inc, Enzon Pharmaceuticals Inc Soar Midday
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) jumped +18.21% and continues on what has been a solid month-long run, its price up +21.73% since May 12th. Carl Icahn has maintained a 5.9-million-share position in the biotech firm across several quarters.
Update: Enzon Pharmaceuticals, Inc. Short Interest Grows by 20.3%
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) has witnessed a colossal rise of 20.3% or 18,868 shares in its short figure.
Share Price of Enzon Pharmaceuticals, Inc. Drops by -4.55%  Markets Bureau
Enzon Pharmaceuticals, Inc. (ENZN): Insiders Aren't Crazy About It
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) was in 15 hedge funds' portfolio at the end of the first quarter of 2013.
Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes ...
On Friday, shares in Enzon Pharmaceuticals Inc. fluctuated between $1.08 and $1.29 before ending the session 14.29% lower at $1.08.
Related articles »  
Biotech News Bundle: Protalix BioTherapeutics (PLX), Enzon Pharmaceuticals ...
Protalix BioTherapeutics Inc. (NYSEMKT:PLX) jumped 8.30% after news that the company Pfizer Inc. (NYSE:PFE) declared that the U.S.
Related articles »